Cell And Gene Therapy Manufacturing Market (Therapy Type: Cell, Gene Therapy Manufacturing; By Scale: Pre-commercial/ R&D Scale, Commercial Scale Manufacturing; By Mode: Contract, In-house Manufacturing; By Workflow: Cell Processing, Cell Banking, Process Development, Fill & Finish Operations) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

Published Date : Jul 2021 | No. of Pages : 150+ Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Cell And Gene Therapy Manufacturing Market, By Therapy Type

7.1.  Cell And Gene Therapy Manufacturing Market, By Therapy Type, 2020-2030

7.1.1.    Cell Therapy Manufacturing

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Gene Therapy Manufacturing

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Cell And Gene Therapy Manufacturing Market, By Scale Type

8.1.  Cell And Gene Therapy Manufacturing Market, By Scale Type, 2020-2030

8.1.1.    Pre-commercial/ R&D Scale Manufacturing

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Commercial Scale Manufacturing

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Cell And Gene Therapy Manufacturing Market, By Mode

9.1.  Cell And Gene Therapy Manufacturing Market, By Filling Material, 2020-2030

9.1.1.    Contract Manufacturing

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    In-house Manufacturing

9.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Cell And Gene Therapy Manufacturing Market, By Workflow

10.1.       Cell And Gene Therapy Manufacturing Market, By End-use, 2020-2030

10.1.1. Cell Processing

10.1.1.1.     Market Revenue and Forecast (2016-2030)

10.1.2. Cell Banking

10.1.2.1.     Market Revenue and Forecast (2016-2030)

10.1.3. Process Development

10.1.3.1.     Market Revenue and Forecast (2016-2030)

10.1.4. Fill & Finish Operations

10.1.4.1.     Market Revenue and Forecast (2016-2030)

10.1.5. Analytical And Quality Testing

10.1.5.1.     Market Revenue and Forecast (2016-2030)

10.1.6. Raw Material Testing

10.1.6.1.     Market Revenue and Forecast (2016-2030)

10.1.7. Vector Production

10.1.7.1.     Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Cell And Gene Therapy Manufacturing Market, Regional Estimates and Trend Forecast

11.1.       North America

11.1.1. Market Revenue and Forecast, By Therapy Type (2016-2030)

11.1.2. Market Revenue and Forecast, By Scale Type (2016-2030)

11.1.3. Market Revenue and Forecast, By Mode (2016-2030)

11.1.4. Market Revenue and Forecast, By Workflow(2016-2030)

11.1.5. U.S.

11.1.5.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.1.5.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.1.5.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.1.5.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.1.6. Rest of North America

11.1.6.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.1.6.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.1.6.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.1.6.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.2.       Europe

11.2.1. Market Revenue and Forecast, By Therapy Type (2016-2030)

11.2.2. Market Revenue and Forecast, By Scale Type (2016-2030)

11.2.3. Market Revenue and Forecast, By Mode (2016-2030)

11.2.4. Market Revenue and Forecast, By Workflow(2016-2030)

11.2.5. UK

11.2.5.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.2.5.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.2.5.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.2.5.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.2.6. Germany

11.2.6.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.2.6.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.2.6.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.2.6.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.2.7. France

11.2.7.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.2.7.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.2.7.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.2.7.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.2.8. Rest of Europe

11.2.8.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.2.8.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.2.8.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.2.8.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.3.       APAC

11.3.1. Market Revenue and Forecast, By Therapy Type (2016-2030)

11.3.2. Market Revenue and Forecast, By Scale Type (2016-2030)

11.3.3. Market Revenue and Forecast, By Mode (2016-2030)

11.3.4. Market Revenue and Forecast, By Workflow(2016-2030)

11.3.5. India

11.3.5.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.3.5.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.3.5.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.3.5.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.3.6. China

11.3.6.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.3.6.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.3.6.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.3.6.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.3.7. Japan

11.3.7.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.3.7.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.3.7.3.     Market Revenue and Forecast, By Mode 2016-2030)

11.3.7.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.3.8. Rest of APAC

11.3.8.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.3.8.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.3.8.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.3.8.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.4.       MEA

11.4.1. Market Revenue and Forecast, By Therapy Type (2016-2030)

11.4.2. Market Revenue and Forecast, By Scale Type (2016-2030)

11.4.3. Market Revenue and Forecast, By Mode (2016-2030)

11.4.4. Market Revenue and Forecast, By Workflow(2016-2030)

11.4.5. GCC

11.4.5.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.4.5.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.4.5.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.4.5.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.4.6. North Africa

11.4.6.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.4.6.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.4.6.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.4.6.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.4.7. South Africa

11.4.7.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.4.7.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.4.7.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.4.7.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.4.8. Rest of MEA

11.4.8.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.4.8.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.4.8.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.4.8.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.5.       Latin America

11.5.1. Market Revenue and Forecast, By Therapy Type (2016-2030)

11.5.2. Market Revenue and Forecast, By Scale Type (2016-2030)

11.5.3. Market Revenue and Forecast, By Mode (2016-2030)

11.5.4. Market Revenue and Forecast, By Workflow(2016-2030)

11.5.5. Brazil

11.5.5.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.5.5.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.5.5.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.5.5.4.     Market Revenue and Forecast, By Workflow(2016-2030)

11.5.6. Rest of LATAM

11.5.6.1.     Market Revenue and Forecast, By Therapy Type (2016-2030)

11.5.6.2.     Market Revenue and Forecast, By Scale Type (2016-2030)

11.5.6.3.     Market Revenue and Forecast, By Mode (2016-2030)

11.5.6.4.     Market Revenue and Forecast, By Workflow(2016-2030)

Chapter 12.  Company Profiles

12.1.             Thermo Fisher Scientific

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2.             Merck KGaA

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3.             Lonza

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4.             Catalent Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5.             Takara Bio Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6.             F. Hoffmann-La Roche Ltd

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7.             Wuxi Advanced Therapies

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8.             Samsung Biologics

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9.             Boehringer Ingelheim

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10.           Novartis AG

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Hitachi Chemical Co., Ltd.

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           Cellular Therapeutics

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           Miltenyi Biotec

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

12.14.           Bluebird Bio Inc.

12.14.1.               Company Overview

12.14.2.               Product Offerings

12.14.3.               Financial Performance

12.14.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.             Primary Research

13.2.             Secondary Research

13.3.             Assumptions

Chapter 14.  Appendix

14.1.             About Us

Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Medical Digital Imaging Systems Market (By Type: X-ray, MRI, Ultrasound, CT, Nuclear Imaging; By Technology: 2D, 3D/4D) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. Pharmacy Benefit Management Market (By Business Model: Standalone, Health Insurance Providers, Retail Pharmacy; By End Use: Commercial, Federal) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. In Vitro Diagnostics Market (By Product: Reagents, Instruments; By Technology: Immunoassay, Molecular Diagnostics; By Application: Infectious Diseases, Diabetes, Oncology, Cardiology; By End User: Hospitals, Laboratories, Home-care, Others) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. Clinical Trials Market (By Phase: Phase I, II, III, IV; By Study Design: Interventional, Observational; By Indication: Oncology, Diabetes) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Compounding Pharmacies Market (By Therapeutic Area: Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements; By Product: Oral, Liquid Preparations, Topical, Rectal, Others; By Application: Pediatric, Adult, Geriatric, Veterinary; By Compounding Type: PIA, CUPM, PDA; By Sterility: Sterile, Non-sterile; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022 – 2030

    Read more...